4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001608936-25-000014
PRESIDENT AND CEO sold 33,374 shares at $9.06 ($302,368)
- PRESIDENT AND CEO acquired 83,666 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chacko Jacob PRESIDENT AND CEO | 2025-12-15 | Option exercise | +83,666 | 615,085 | D | ||
| Chacko Jacob PRESIDENT AND CEO | 2025-12-16 | Sale | −33,374 | $9.06 | $302,368 | 581,711 | D |
| Derivatives | |||||||
| Chacko Jacob PRESIDENT AND CEO | 2025-12-15 | Option exercise · Restricted Stock Unit | −22,000 | 0 | D | ||
| Chacko Jacob PRESIDENT AND CEO | 2025-12-15 | Option exercise · Restricted Stock Unit | −28,333 | 28,334 | D | ||
| Chacko Jacob PRESIDENT AND CEO | 2025-12-15 | Option exercise · Restricted Stock Unit | −33,333 | 66,667 | D | ||
| Open-market sales · 33,374 sh · avg $9.06 · $302,368 | |||||||
Loading xslF345X05/form4-12182025_121249.xml…